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The endothelial cells that form the blood–brain barrier (BBB) are
coated with glycocalyx, on the luminal side, and with the base-
ment membrane and astrocyte endfeet, on the abluminal side.
However, it is unclear how exactly the glycocalyx and extravascu-
lar structures contribute to BBB properties. We used two-photon
microscopy in anesthetized mice to record passive transport
of four different-sized molecules—sodium fluorescein (376 Da),
Alexa Fluor (643 Da), 40-kDa dextran, and 150-kDa dextran—
from blood to brain, at the level of single cortical capillaries.
Both fluorescein and Alexa penetrated nearly the entire glyco-
calyx volume, but the dextrans penetrated less than 60% of
the volume. This suggested that the glycocalyx was a barrier
for large but not small molecules. The estimated permeability
of the endothelium was the same for fluorescein and Alexa but
several-fold lower for the larger dextrans. In the extravascular
compartment, co-localized with astrocyte endfeet, diffusion coef-
ficients of the dyes were an order of magnitude lower than in
the brain parenchyma. This suggested that the astrocyte endfeet
and basement membrane also contributed to BBB properties. In
conclusion, the passive transport of small and large hydrophilic
molecules through the BBB was determined by three separate
barriers: the glycocalyx, the endothelium, and the extravascular
compartment. All three barriers must be taken into account in
drug delivery studies and when considering BBB dysfunction in
disease states.
blood–brain barrier | glycocalyx | astrocytes | diffusion | permeability
The blood–brain barrier (BBB) is a unique defense systemthat protects the brain from harmful agents and pathogens.
Unfortunately, the BBB also restricts entry of a wide range of
drugs developed to treat brain diseases. Tracer kinetic analysis
was developed to quantify whole-brain uptake of compounds,
but that technique has provided little information about the
microstructure of the BBB (1–4). Advances in confocal and two-
photon fluorescence imaging have allowed researchers to study
the BBB at the microscopic level, on scales that range from an
entire brain region down to a single vessel (5–8).
The majority of two-photon microscopy studies of BBB per-
meability have focused on imaging a brain region (typically
spanning several hundred microns) and recording fluorescence
intensities from extra- and intravascular compartments. Those
data allowed calculations of BBB permeability based on theoret-
ical models (7, 9, 10). In those models, BBB permeability was
described as an average property of all vessels in the imaged
region.
Those experiments could not resolve the contributions of indi-
vidual vessels and even less the composition of the barrier.
Several studies have, however, suggested that, in addition to the
vascular endothelium, structures associated with the endothe-
lium might also act as barriers (11–16). These structures include
the endothelial glycocalyx, basement membrane, and astrocyte
endfeet.
Here, we hypothesized that the BBB consists of a sequence
of barriers, each limiting blood-to-brain transport of small and
large molecules. To test this hypothesis, we performed high-
resolution two-photon imaging of single capillaries and intro-
duced fluorescent dyes into the bloodstream. We also used
different fluorescent dyes to label the glycocalyx and astrocyte
endfeet, which enabled us to associate fluorescent tracers that
crossed the BBB with each anatomical component. Our data
suggested that the BBB consisted of at least three different bar-
riers that individually affected BBB permeability. The properties
of this “tripartite” BBB should be considered when designing
the delivery of large drug molecules and when studying disease
states.
Results
Imaging Setup. We used fast-scanning two-photon microscopy to
record real-time images of single brain blood vessels oriented
perpendicular to the focal plane. During these recordings, we
continuously injected fluorescent dyes into the blood (Fig. 1 A
and B). We evaluated changes in the distribution of fluores-
cence intensity outside the vessel, caused by the dye traversing
the BBB. We performed this evaluation with a theoretical model
(see Theory), based on the cylinder concept developed by Krogh.
This model was designed to analyze the blood-to-brain transfer
of an inert, diffusible solute that could permeate blood vessel
walls (17). A blood vessel was modeled as an infinite cylinder
inside a medium that was rotationally symmetric about the vessel
(Fig. 1C). Therefore, we only analyzed data from blood ves-
sels that were oriented perpendicular to the focal plane (Fig.
1D). To assist in the interpretation of the recorded images,
we estimated the resolution of our microscope inside the brain
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Fig. 1. The imaging setup and pipeline of data analysis. (A) Images of brain vessels were collected from anesthetized mice through a cranial window with
a two-photon microscope. Fluorescent dyes were continuously injected into a femoral vein with a pump. (B) An image of a brain region, showing blood
vessels filled with Dex150. Only blood vessels oriented perpendicular to the focal plane were recorded and analyzed. (C) We modeled the selected blood
vessels as cylinders, oriented perpendicular to the focal plane (gray area) and surrounded by a medium that was rotationally symmetric about the vessel. (D)
Reconstruction of capillary geometry from images taken at different depths. The vessel is perpendicular to the focal plane, and it is approximately a cylinder
for 10 µm above and below the focal plane. (E) Comparison between fast-scanned images of two blood vessels, one viewed from the side, another viewed
in cross-section. When blood cells are imaged, they replace the plasma and, hence, the fluorescent dye is absent (“filled” vessel). Consequently, filled vessels
have dark shadows of various shapes inside them. (F) Before analysis, all recorded images were stabilized to correct for tissue movement (see SI Appendix,
Image Registration). (G) To estimate the diffusion coefficient of the dye, D*, in the extravascular compartment, stabilized images were block-averaged in
time. (H) The average fluorescence intensity in the central part of the vessel (dotted white circles) was calculated for each recorded image and plotted as a
function of time (Right). The points of highest intensity (blue) represent the fluorescence intensity in plasma. Images without blood cells (“empty” vessels)
that corresponded to these points were extracted (SI Appendix, Fig. S6) and used to calculate the coefficient, αg, of dye partitioning between the plasma
and the glycocalyx. The points of lowest intensity (red) correspond to most of the vessel volume being occupied by a blood cell (“filled” vessel). (Scale
bar, 2 µm.)
with quantum dots that bind to the endothelial glycocalyx (see
Estimating the Resolution of a Two-Photon Microscope Inside
the Brain).
High acquisition rates (1–2 ms per image) allowed us to cap-
ture some images of vessels, when they contained only plasma
without blood cells (called empty vessels; Fig. 1 E and H). Blood
cells perturbed the structure of the endothelial glycocalyx (11)
and reduced intravascular fluorescence by replacing the dye-
containing plasma. Only images of the empty vessel showed the
unperturbed distribution of the fluorescent dye in the vessel
lumen. Therefore, we identified images of empty vessels (Fig.
1H) and used them to estimate the distribution of fluorescence
intensity inside the vessel. In particular, we analyzed the parti-
tioning of the fluorescent dye between the center of the vessel
and the glycocalyx.
A Tripartite BBB. We hypothesized that the entire region that sep-
arates the vessel lumen from the brain parenchyma contributes
to the BBB (Fig. 2A). Thus, the glycocalyx on the luminal side of
the endothelium, the endothelium itself, and the extravascular
compartment all contribute to the BBB. We found experimental
support for this hypothesis as follows.
We located these three compartments in images by locat-
ing the endothelial glycocalyx and the astrocyte endfeet. To
this end, the glycocalyx was labeled with Alexa Fluor (AF)
594-conjugated wheat germ agglutinin (WGA-Alexa; red in
Fig. 2B), and the endfeet were labeled with sulforhodamine
101 (SR101; green in Fig. 2B). Then we analyzed the distri-
bution across the three compartments independently for each
of four diffusing dyes. Fig. 2C shows the distribution of one
of the dyes, the 150-kDa fluorescein isothiocyanate-dextran
(Dex150).
We based our definition of the extravascular compartment on
the values we found for the diffusion coefficients in this region
and the large difference between these values and the values
found in the brain parenchyma. Starting at the peak of the fluo-
rescence emitted by astrocyte endfeet (dashed circle in Fig. 2A),
our extravascular compartment spanned the region, in which
the experimental distribution of fluorescence agreed with the
fitted solution to Eq. 1. Note that this fitted solution assigns
a given dye a diffusion coefficient that is constant in time and
space throughout the compartment. This simple but demanding
property defines the compartment.
This extravascular compartment did not include the space clos-
est to the vascular endothelium, because there, the distributions
of fluorescence were not typically rotationally symmetric. More-
over, we could not determine an exact boundary between the
extravascular compartment and the brain parenchyma from our
data. We believe that a continuous transition between the two
spaces was more likely.
We treated the space between the glycocalyx and the ex-
travascular compartment as a single compartment, called “the
E9430 | www.pnas.org/cgi/doi/10.1073/pnas.1802155115 Kutuzov et al.
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Fig. 2. Components of the tripartite BBB. Glycocalyx and astrocyte endfeet
were labeled and used as landmarks to locate the components of the tri-
partite BBB on recorded images. (A) Simplified diagram showing the main
components of the BBB. We partitioned the BBB into three compartments—
glycocalyx (red), endothelium (purple), and extravascular compartment
(green)—based on their functional transport properties (glycocalyx parti-
tion coefficient, permeability, and diffusion coefficients) revealed by our
data. The transport properties of these three compartments are analogous
to three Ohmic resistors connected in series (schematic on the right side in
A; see Discussion for more explanation). Thus, for a given concentration dif-
ference across the BBB, the glycocalyx and the extravascular compartment
reduce the drop in concentration across the endothelium, and hence reduce
the flux through it, in a manner that depends on the type of molecules in
question. (B) Glycocalyx (red) and astrocyte endfeet (green) were labeled
with WGA-Alexa and SR101, respectively. (C) Distribution of Dex150 fluo-
rescence in the vessel lumen. The intensity is normalized by its maximum
value. (D) Radial intensity profiles were obtained by selecting a sector (gray
area, in B and C) and averaging the pixel values located at the same dis-
tances from the center of the vessel (SI Appendix, Fig. S1). The maxima
of WGA-Alexa and SR101 fluorescence intensities defined the inner and
outer boundaries, respectively, of the endothelium. The partition coeffi-
cient, αg, is the ratio between the fluorescence intensities of the dye at
the peak of the WGA-Alexa distribution (red in B) and in the plasma (C).
Error bars were estimated, as described in SI Appendix, Statistics. (Scale
bar, 2 µm.)
endothelium” (see Fig. 2D). Based on the anatomy of the neu-
rovascular unit (18, 19), this space, in addition to the vascular
endothelium, may contain fragments of basement membrane,
perivascular space, and pericytes, which we did not identify on
our fluorescence images.
Our definitions of the endothelium and the extravascular
compartment were based not on their anatomy but on their
functional transport properties (permeability and diffusion coef-
ficients) revealed by our data. The third compartment that we
studied was the glycocalyx, located between the vessel lumen and
the endothelium (see Fig. 2D).
Estimation of the Glycocalyx Partition Coefficient. We defined
the partition coefficient, αg , as the ratio of two fluorescence
intensities. The first intensity was the Dex150 fluorescence at
the point that it coincided with the peak of the WGA-Alexa
fluorescence, which labeled the glycocalyx (Fig. 2D); the sec-
ond intensity was the Dex150 fluorescence in the plasma, at
the middle of the vessel. Thus, the αg could be interpreted
as the fraction of glycocalyx volume that was accessible to the
dye-containing plasma (20). Fig. 2D shows that the fluores-
cence intensity of Dex150 was uniform in the center of the
vessel, but it dropped by almost 50% in the glycocalyx. Fig. 3
A–F summarizes the values obtained for αg with all four dyes,
and SI Appendix, Fig. S8 discusses potential sources of bias
in these estimates. We found no difference in αg between so-
dium fluorescein (NaF; mean ± SEM: 0.93 ± 0.02) and AF
(mean± SEM: 0.91 ± 0.02). For both NaF and AF, αg values
were roughly twice as large as the αg value of 40-kDa fluores-
cein isothiocyanate-dextran (Dex40; mean ± SEM: 0.56 ± 0.03)
and Dex150 (mean ± SEM: 0.44 ± 0.03). Dex40, which was
smaller than Dex150, penetrated the glycocalyx more efficiently
than Dex150 (Fig. 3F). When we treated the glycocalyx with
the enzyme hyaluronidase, αg of Dex150 increased from 0.44±
0.03 (mean ± SEM) to 0.80 ± 0.05 (mean ± SEM; Fig. 3F),
which was consistent with the findings reported by Henry and
Duling (21).
Diffusion Explains the Observed Transport of Fluorescent Dyes in
the Extravascular Compartment. For the quantitative analysis of
dye diffusion, we applied polar coordinates with origin in the
center of the vessel (SI Appendix, Fig. S1). We found that the
instantaneous distributions of fluorescence did not depend on
the polar angle. This rotational symmetry of the data simpli-
fied the ensuing analysis by making the radial dimension the
only spatial dimension of relevance. By allowing us to average
data values over the polar angle, the rotational symmetry also
improved the statistics of data. This made it more challenging to
fit a model to data and hence more significant that we achieved
to do so.
Fig. 3 G and H shows how Dex150 traverses the brain endothe-
lium and travels beyond the astrocyte endfeet when a sufficiently
large concentration gradient is created across the BBB. We
collected and analyzed data from vessels loaded with NaF,
AF, Dex40, or Dex150. We found that the changes in fluores-
cence intensity, Iev , for dyes in the extravascular compartment
of either small capillaries (3–5 µm diameter) or larger vessels
(>10 µm) could be described with the radial reaction–diffusion
equation:
∂Iev
∂t
=D∗
(
∂2Iev
∂r2
+
1
r
∂Iev
∂r
)
− kr Iev , [1]
where D∗ is the diffusion coefficient of the dye in the extravas-
cular compartment, r is the radial distance from the center of
the vessel, and kr Iev is a reaction term that accounts for pho-
tobleaching and other first-order kinetic reactions. The value of
kr depends on the incident laser intensity, which we were not
able to measure. We did not analyze the values we obtained
for kr , apart from noting that the four kr values for Dex150
given in Table 1 were consistent with a single value. Fig. 4 A
and B shows examples of fits of the model to experimental data
for NaF (χ2 =2.2) and Dex150 (χ2 =2.5). An example of the
diffusion of Dex150 into the extravascular compartment of a
penetrating arteriole is shown in SI Appendix, Fig. S7. Diffusion
coefficients for Dex150 suggested that the values were iden-
tical for small capillaries and large vessels (Fig. 4E). Table 1
summarizes the values of diffusion coefficients and reaction con-
stants. The values of D∗ for all fluorescent dyes studied (Table
1) were approximately one order of magnitude lower than those
reported for molecules of similar size in the brain parenchyma
(22–25).
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Fig. 3. Analysis of the glycocalyx partition coefficient of the dye and its diffusion in the extravascular compartment. Glycocalyx partition coefficients (αg)
were determined for (A) NaF, (B) AF, (C) Dex40, (D) Dex150, and (E) Dex150 (after enzymatically treating the glycocalyx). All extracted images of empty
vessels (Fig. 1H) were normalized to the fluorescence intensity measured at the center of the vessel, and then, the normalized images were averaged. The
resulting images of plasma fluorescence (Left) and glycocalyx fluorescence (Middle) were split into eight sectors (a single sector is shown in gray); for each
sector, the αg was estimated from the radial intensity distributions (Right). The mean value of all eight sectors was used as the total estimated partition
coefficient, αg. For the dyes that effectively permeated the glycocalyx (NaF and AF), the intensity of plasma fluorescence (left column) in the center of
the vessel was almost the same as the intensity in the glycocalyx. For the dyes that permeated the glycocalyx less effectively (Dex40 and Dex150), the
plasma fluorescence distribution was narrower (left column), and the plasma fluorescence intensity in the glycocalyx was reduced. The relative reduction
in fluorescence was quantified as αg. (F) Partition coefficients show that NaF and AF were distributed nearly throughout the entire glycocalyx volume,
whereas Dex40 and Dex150 occupied less than 60% of the glycocalyx. Enzymatic treatment of the glycocalyx significantly increased the partition coefficient
for Dex150. (G) Astrocyte endfeet fluorescence (Left) and its radial intensity profile (Right), obtained by azimuthal averaging of pixel intensities. (H) Time
sequence of Dex150 fluorescence images (Left) and corresponding radial intensity profiles (Right) show the dye distribution as it penetrates the endothelium
and travels into the extravascular compartment (outside the white circle). Before analysis, all images were stabilized and block-averaged (see Fig. 1 F and
G). Pixels in the center of the vessel were oversaturated to enhance the weaker fluorescence in the extravascular compartment. Only data with rotationally
symmetric fluorescence distributions were used for the analysis, which allowed us to model these data with Eq. 1. For a discussion on factors that can affect
the extravascular fluorescence intensity, see SI Appendix, Fig. S9. Error bars were estimated as described in SI Appendix, Statistics. (Scale bar, 2 µm.) *P <
0.05, one-way ANOVA with Tukey’s post hoc test. **P < 0.001, Wilcoxon rank-sum test.
Permeability of the Vascular Endothelium. We estimated the per-
meability, P , of the vascular endothelium, as described in Fig. 4
C and D (see also Theory). The quality of the one-parameter fits
shown in Fig. 4 C and D demonstrated that
i) our interpretation of the space-time distribution of fluores-
cence outside the blood vessel showed that the flux away
from the vessel was simply proportional to the independently
observed fluorescence inside the vessel;
E9432 | www.pnas.org/cgi/doi/10.1073/pnas.1802155115 Kutuzov et al.
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Table 1. Diffusion coefficients (D*), endothelial permeabilities
(P), and reaction constants (kr) for NaF, AF, Dex40, and Dex150
Molecule D*, 10−8 cm2/s P, 10−7 cm/s kr , 10−2 s−1
NaF† 1.30± 0.16 (8) 3.91± 0.41 (8) 6.3± 1.4 (8)
AF† 1.25± 0.09 (8) 3.95± 0.18 (8) 0.8± 0.6 (8)
Dex40† 0.55± 0.07 (8) 1.40± 0.15 (8) 2.6± 0.5 (8)
Dex150† 0.19± 0.06 (8) 0.51± 0.14 (8) 1.7± 0.5 (8)
Dex150‡ 0.25± 0.07 (6) 0.62± 0.17 (6) 2.3± 0.6 (6)
Dex150† ,§ 0.18± 0.06 (8) 0.38± 0.09 (8) 3.1± 0.8 (8)
Dex150† ,¶ 0.27± 0.05 (6) 1.24± 0.20 (6) 1.5± 0.7 (6)
Data represent the mean ± SEM of n independent measurements.
†Diameter ≈3–5 µm.
‡Diameter > 10 µm.
§Intracarotid injection of saline (control).
¶Intracarotid injection of mannitol.
ii) since the vessel was the only source of fluorophores in the
experiment, the fluorophores were transported across the
vascular endothelium; and
iii) this transport was proportional to the difference in concen-
tration across the endothelium—in effect the concentration
inside, in the glycocalyx, because the concentration out-
side was negligible in comparison. Consequently, the trans-
port across the endothelium could be described by a single
parameter, its permeability.
Although these results were not surprising, they lent strong
experimental support to our data analysis, both its logic and its
execution.
The permeabilities of vessels to dyes are given in Table 1 and
Fig. 4F. We found no difference between the permeabilities of
NaF and AF but lower permeabilities for the dextrans, More-
over, the permeability was lower for Dex150 than for Dex40,
which suggested a size-dependent mechanism of permeation. We
did not find a significant difference in permeabilities between
small capillaries (3–5 µm diameter) and larger vessels.
This approach was tested on vessels after the BBB was com-
promised by injecting mannitol. Mannitol has been used rou-
tinely to increase the BBB permeability (26, 27). We found that
an intracarotid injection of mannitol caused a > 2-fold increase
in BBB permeability to Dex150 and did not change the diffusion
coefficient of Dex150 in the extravascular compartment (Fig. 4
E and F); thus, mannitol did not affect the permeability of the
extravascular compartment, even when it strongly affected the
vascular endothelium. In 6 out of 22 selected vessels, the initial
circular symmetry of the fluorescence distribution was preserved.
The data from these six vessels were used for our analysis. In
16 out of 22 vessels, the circular symmetry was disrupted by
the treatment. Data from those vessels were excluded from our
analysis.
Discussion
The Tripartite BBB Acts as Three Sequential Resistors. The BBB that
emerged from this analysis can be thought of as three Ohmic
resistors connected in series: the glycocalyx, the endothelium,
and the extravascular compartment (Fig. 2A). A concentration
difference across the BBB corresponds to a voltage difference
across the three resistors. The flux of molecules across the BBB
corresponds to the electrical current through the three resistors.
This analogy is deep, because permeability and conductance are
simply different names for parameters that quantify a linear rela-
tionship between cause (difference in voltage/concentration) and
effect (current/flux). Thus, because the glycocalyx and extravas-
cular compartments function as barriers in comparison with
the vessel lumen and the brain parenchyma, respectively, for
a given concentration difference between the vessel lumen
and the parenchyma, they reduce the concentration difference
across the endothelium, and hence, they reduce the flux through
it. This effect is greater for larger molecules, because they
encounter greater resistance in the glycocalyx. Moreover, as
the resistance in the extravascular compartment slows diffu-
sive transport away from the blood vessel, potential pathogens
may be exposed to immune cells near the blood vessel for a
longer time.
In Vivo Estimates of Fluorophore Partitioning into the Glycocalyx Pro-
vide a Better Description than Glycocalyx Thickness. We reported
glycocalyx partition coefficients for fluorescent dyes entering
into the glycocalyx in single vessels in vivo. In our opinion, this
coefficient is more descriptive than the glycocalyx thickness or
related quantities reported elsewhere (13, 21, 28–30). The par-
tition coefficient is specific to individual molecules, and it can
be interpreted as the fraction of the glycocalyx volume that is
accessible to the specific molecule. In contrast, the glycocalyx
thickness does not contain molecule-specific information. We
propose that the partition coefficient can be interpreted in terms
of the glycocalyx microstructure. Electron microscopy images
have demonstrated that the glycocalyx is a collection of dense,
bush-like structures, which cover the surface of an endothelial
cell (31, 32).
We showed that NaF and AF distributed nearly throughout
the entire glycocalyx volume, which indicated that the glycoca-
lyx did not serve as a barrier to small molecules, like NaF and
AFs; instead, the glycocalyx was essentially equivalent to blood
plasma. However, based on our results with Dex40 and Dex150,
larger molecules were less able to penetrate the dense glycocalyx
structures. An integration of the fluorescence signals over low-
and high-density regions showed that Dex150 fluorescence in the
glycocalyx was 44% of its intensity in the blood plasma (Fig. 3F).
When a molecule has a low glycocalyx partition coefficient,
it may only reach a fraction of the endothelial surface, which
reduces its flux through the BBB and, consequently, its total
brain uptake. Our results were supported by the findings of
Vink and Duling, who demonstrated that small dyes and low-
molecular weight dextrans could penetrate the glycocalyx of
cremaster muscle capillaries, but 70 kDa anionic and neutral
dextrans were confined to the central part of the capillary
(11, 33).
Knowledge of the glycocalyx partition coefficient might
increase the accuracy of measurements of the glycocalyx thick-
ness. Previously, these measurements typically relied on the
assumption that high-molecular weight anionic dextrans (like
70-kDa dextran) could not permeate the glycocalyx (30).
Nieuwdorp et al. (34) developed a quantitative approach for
measuring the glycocalyx volume in human patients. They
assumed that a reference fluorescent dye could distribute
throughout the entire glycocalyx volume. In a review of that
approach, Michel and Curry (20) questioned that assumption
and suggested that a method for measuring the glycocalyx par-
tition coefficient was required. In the present study, we have
provided that method.
The Extravascular Compartment Is also a Diffusion Barrier. After
a molecule in the blood has traversed the glycocalyx and the
endothelium, it encounters the extravascular compartment. With
the simplest possible reaction–diffusion model, we showed that,
for the four fluorescent dyes we studied, the diffusion coef-
ficients in the extravascular compartment were approximately
one order of magnitude lower than the diffusion coefficients of
similar-sized compounds in the brain parenchyma (22, 25).
Once a molecule has crossed the endothelium, we expect a
significant increase in the geometric path length of its radial
diffusion: Instead of diffusing radially, the molecule is forced
to travel along the astrocyte endfeet (and possibly the peri-
cyte membrane) to find the exit points between the neighboring
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Fig. 4. Diffusion coefficients of the extravascular compartment and permeabilities of the vascular endothelium. (A and B) Experimentally measured radial
distributions of fluorescence intensity of NaF and Dex150 (points with error bars) and the space-time distribution of fluorescence according to simple dif-
fusion with bleaching, as described by Eq. 1 (lines), which was fitted to the experimental fluorescence data. Different colors indicate different times of
measurement and solutions to Eq. 1 at corresponding times. The dashed line indicates the fluorescence of the astrocyte endfeet. (Insets) Histograms of
the standardized residuals of the fits shown. A standard Gaussian distribution of standardized residuals indicates a perfect fit. For comparison, a standard
Gaussian distribution is plotted (black line) on each histogram. (C and D) Fluorescence intensity in the glycocalyx plotted against the flux across the endothe-
lium. The fluorescence intensities in the glycocalyx are experimental results from inside the blood vessel, and the fluxes across the endothelium are derived
from the dependence of the extravascular fluorescence intensity on radial distance. The slope of the straight line through the origin was fitted to the data
shown. The permeability of the vascular endothelium was estimated as the reciprocal of that slope (SI Appendix, Eq. 6). (Insets) Same as in A and B. (E and
F) Vessel size and BBB integrity effects on (E) diffusion coefficients of fluorescent dyes in the extravascular compartment and (F) endothelial permeability.
Mannitol was used to compromise the integrity of the BBB. Individual points represent measurements in different mice; horizontal lines represent the mean,
and error bars are the±SEM. Error bars were estimated as described in SI Appendix, Statistics. *P < 0.05, one-way ANOVA with Tukey’s post hoc test. **P <
0.01, Wilcoxon rank-sum test.
endfeet (Fig. 2A). Moreover, astrocyte endfeet are connected
to each other through gap-junctions, and they are connected
to endothelial cells through complex interactions with the basal
lamina and extracellular matrix (figure 3 in ref. 18). This tight
complex may serve as an additional barrier to compounds that
cross the vascular endothelium (18, 19, 35, 36). Indeed, Nuriya
et al. (15) demonstrated that astrocyte endfeet formed a barrier
for compounds moving from the brain parenchyma to the blood
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vessel. Several studies have also shown that compounds in the
perivascular spaces (19) were hindered in a size-dependent man-
ner (16, 37), consistent with the size dependence of the diffusion
coefficients we observed (Table 1).
Convective transport occurs in the perivascular spaces of large
brain vessels and inside the brain ventricles (37–41), but it is
debatable whether convection is important for the transport
of compounds within the brain parenchyma (18, 42). Here,
we demonstrated that the local fluorescence intensity in the
extravascular compartment changed over time and space in a
manner consistent with simple diffusion. The radial diffusion
coefficient was constant in space and time. Consequently, we
could exclude convection as a mechanism of transport.
Diffusion coefficients in the brain parenchyma are typically
estimated by injecting a fluorescent dye through a pipette and
modeling the spatiotemporal changes in local fluorescence.
That approach assumes that the medium is homogeneous and
isotropic across hundreds of microns around the injection site
(22, 43). On the other hand, to simplify our calculations for
the extravascular compartment, we only needed to assume that
the medium was rotationally invariant with respect to rotations
around the center of the vessel; thus, we only studied vessels
that exhibited this property. Because the radial span of the
vessel was only a few microns, we assumed, and we could con-
firm, that the vessel was the only source of fluorescent dye in a
given extravascular compartment. However, on a larger spatial
scale, all blood vessels are sources of fluorescence in the brain,
which makes modeling prohibitively complex. This complexity
prevented us from analyzing diffusion in the brain parenchyma
based on fluorescence.
Shi et al. estimated the diffusion coefficients of fluorescent
dyes in the space surrounding cerebral blood vessels. They
reported values that agreed well with diffusion coefficients pre-
viously reported for the brain parenchyma. However, although
they used a radial diffusion model that assumed rotational sym-
metry with respect to the vessel, their image data (figure 4a in
ref. 8) showed an absence of the symmetry, which challenges the
accuracy of their estimates. Our results suggested two different
diffusion coefficients for each dye. One coefficient described dif-
fusion in the extravascular compartment, and the other described
diffusion in the brain parenchyma. Single-molecule tracking
might be a suitable method for measuring both diffusion coeffi-
cients for a single dye molecule (44). That approach would have
high reliability because it would not require switching methods
between measurements (45).
Vascular Endothelium Permeability from Two-Photon Images. Early
quantitative methods showed that the permeability of blood ves-
sels in the brain was much smaller than in other tissues (46, 47).
Currently, microscopic imaging methods are routinely used to
estimate BBB permeability both in vitro (48, 49) and in vivo
(7–9, 50). In the present work, we injected fluorescent dyes
intravenously (i.v.), which resulted in minimal interference with
cerebral blood flow compared with other in vivo methods (8,
50). We developed a method for measuring the resulting plasma
fluorescence intensity directly from images without red blood
cells. For diffusion in the vessel periphery, we measured only
the fluorescence close to the vessel (3–5 µm), and the experi-
ments were brief (1–2 min). Thus, we effectively eliminated any
potential contributions to the observed fluorescence from vessels
other than the one on which we focused. Finally, we identified
some anatomical components of the BBB and separated the gly-
cocalyx and extravascular components from the measurement of
vascular endothelium permeability.
The permeabilities presented here were within an order of
magnitude of permeabilities reported previously for fluores-
cent dyes of similar size, both in vivo (8, 50–52) and in vitro
(48, 49, 53, 54). In particular, our estimation of Dex40 per-
meability (1.40± 0.15× 10−7 cm/s) agreed well with other in
vivo estimates of 1.15± 0.23× 10−7 cm/s (table 1 in ref. 8)
and 1.7± 0.9× 10−7 (table 1 in ref. 50). Our permeability for
Dex150 (0.51± 0.14× 10−7 cm/s) was, as expected, lower than
that for Dex70 and higher than that of IgG (table 1 in ref. 8).
Yuan et al. and Shi et al. (8, 50) reported a higher BBB perme-
ability for NaF than our value. However, they studied postcapil-
lary venules, which were shown to exhibit loose BBB architecture
compared with capillaries (55); hence, venules are expected to
have higher BBB permeability than capillaries.
Our finding that estimated permeabilities declined with
increasing dye size (Table 1) was consistent with a paracellular
transport mechanism. It was not surprising that high-molecular
weight polymers, particularly dextrans, could move through nar-
row spaces that are smaller than their size, estimated by the
hydrodynamic radius or the radius of gyration, because the prop-
erties of linear polymers differ from those of rigid particles of
similar size (see SI Appendix, Using Fluorescently Labeled Dex-
trans as Probes to Study Transport in Brain Tissue). The polymer
coil can thread through tight and narrow spaces, by starting at
one of its ends or by starting with a “hernia.” For example,
one can directly visualize how a single 48.5-kbp DNA diffuses
through pores that are approximately seven times smaller than
its radius of gyration (figure 5 in ref. 56). Indeed, experimental
data from glomerular capillaries showed higher permeability for
dextrans than for proteins of similar size (57–60). However, the
probability of dextran passage through the narrow BBB spaces
is much smaller than that of a compact molecule with a diame-
ter similar to a dextran monomer. This low probability results in
very small, but experimentally measurable, BBB permeabilities
to large dextrans.
Another way to cross the BBB is through an endothelial cell.
Particularly, fluid-phase endocytosis has been used to explain
how some proteins and dextrans can penetrate the BBB (61, 62).
If this transport is not limited by the number of vesicles avail-
able for endocytosis, one may expect the flux of dextran through
the BBB to be proportional to the concentration of dextran in
the blood. Consequently, this contribution to the flux of dextran
across the BBB is inseparably included in the permeability we
measure (Fig. 4 C and D).
For hydrophobic compounds that can diffuse through the
endothelial plasma membrane, a threshold exists in the 400–600
Da range, which could supposedly distinguish BBB-permeable
from BBB-nonpermeable molecules (63). We found no evidence
for such a threshold for hydrophilic NaF (376 Da) and AF (643
Da) (Table 1). Our data indicate that the endothelium per-
meability for hydrophilic compounds depends more smoothly
on molecular weight and that the differences in the total flux
of a compound through the BBB depends also on its glycoca-
lyx partition coefficient and on its diffusion coefficient in the
extravascular compartment.
Finally, we showed that mannitol did not change the diffu-
sion coefficient in the extravascular compartment but produced
a more than twofold increase in endothelium permeability.
Our results supported the hypothesis that mannitol induced
endothelial cell shrinkage, which then increased the paracellular
permeability (64).
Limitations of the Model. The method of analysis developed
here applies only to vessels that are oriented perpendicular
to the focal plane. These vessels were not expected to dif-
fer from vessels with different orientations. Larger vessels are
scarcer than small capillaries; thus, it might be challenging, and
hence time-consuming, to find a large vessel with a cylindri-
cal shape and a perpendicular orientation. Our method also
demanded rotational invariance in the distribution of fluores-
cence around the vessel. In the case of the mannitol-disrupted
BBB, this demand was not satisfied for a large fraction of
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the vessels; consequently, those vessels were not studied. For
a more detailed discussion of factors that affect estimates of
the measured extravascular fluorescence intensity and the par-
tition coefficients of the glycocalyx, see SI Appendix, Figs. S8
and S9.
Summary. We have developed and applied a theoretical frame-
work for a quantitative analysis of the BBB in single capillaries.
We isolated the glycocalyx, endothelium, and extravascular com-
partment adjacent to the brain parenchyma. Together, these
three structures form a sequence of diffusional constraints that
may be termed the tripartite BBB. We quantified the trans-
port properties of the three structures in the tripartite BBB
separately, as independent units, by tracking the transfer of fluo-
rescent molecules from the glycocalyx, through the endothelium,
to the extravascular compartment. The next step in understand-
ing the BBB might be to study the processes that regulate
the properties of the glycocalyx, endothelium, and extravascular
compartment in health and disease.
Materials and Methods
Animal Handling. All procedures involving animals were approved by the
Danish National Committee, according to the guidelines of the European
Council’s Convention for the Protection of Vertebrate Animals Used for
Experimental and Other Scientific Purposes (https://www.coe.int/en/web/
conventions/full-list/-/conventions/rms/090000168007a67b). In addition, all
procedures were in compliance with Animal Research: Reporting of in Vivo
Experiments (ARRIVE) guidelines. We used male C57BL/6J, 8–12-wk-old mice
and followed surgical procedures described elsewhere (65). Internal carotid
artery catheterization was based on a previously described method (66).
Anesthesia was induced with intraperitoneal bolus injections of xylazine
(10 mg/kg) and ketamine (60 mg/kg). Ketamine (30 mg/kg) was used to
maintain anesthesia during the experiments. A 2–3-mm cranial window
was drilled over the somatosensory barrel cortex region (Fig. 1A). After the
dura was removed, we applied 0.75% agarose gel to the brain surface and
covered the craniotomy with a glass coverslip.
Materials. We used NaF (Sigma-Aldrich; 1% solution in saline), AF 488 (AF;
Sigma-Aldrich; 0.2% solution in saline), 40 kDa fluorescein isothiocyanate–
dextran (Dex40; Sigma-Aldrich; 2.5% solution in saline), and 150 kDa
fluorescein isothiocyanate–dextran (Dex150; Sigma-Aldrich; 2.5% solution
in saline) as fluorescent dyes, which were injected i.v. using a syringe pump
at a rate of 0.15–0.3 mL/h. Resolution of the two-photon microscope in the
brain was estimated (see section below) using quantum dots conjugated
with WGA (Qdot655-WGA, Thermo Fisher Scientific; 1 µM stock solution
diluted 200 times in saline). Astrocytes were labeled with SR101 (Sigma-
Aldrich; 50 µM in saline) applied to a brain surface. Glycocalyx was labeled
with AF 594-conjugated WGA (WGA-Alexa; Thermo Fisher Scientific; 100
µL of 1 mg/mL solution in saline) injected i.v. 45 min before imaging.
To enzymatically degrade the glycocalyx, we used hyaluronidase (Sigma-
Aldrich type IV-S; 750–3,000 units per milligram; 5 mg in 150 µL saline)
injected into the internal carotid artery 1 h before imaging. Control ani-
mals received the same amount of denatured hyaluronidase heated for 10
min at 95◦. Mannitol (Sigma-Aldrich; 100 µL of 20% solution in saline) was
injected into the internal carotid artery; controls received the same amount
of saline.
Two-Photon Imaging Parameters. Data were recorded with a FluoView
FVMPE-RS two-photon microscope (Olympus) equipped with a MaiTai
DeepSee laser (Millenia Pro, Spectra Physics) and a fast resonant-scanning
system. Imaging was performed with a 25× (N.A. = 1.05) water immersion
objective (Olympus). Samples were illuminated with 800-nm laser light, and
emitted fluorescence was split and recorded into channels equipped with
high-sensitivity GaAsP detectors. Images were sampled at ∼80 Hz; individ-
ual images were recorded for 1–2 ms (depending on the size) at 0.07 µs per
pixel and 0.124 µm per pixel resolution. Recorded data were stored on the
servers of the Department of Neuroscience at the University of Copenhagen,
and they are available upon request.
Estimating the Resolution of a Two-Photon Microscope Inside the Brain. We
used quantum dots conjugated with WGA (referred to as quantum dots
below) to estimate our microscope’s lateral and axial resolutions, ∆XY and
∆Z , respectively, both outside and inside the brain. To assess the per-
formance of our imaging setup, we collected images of quantum dots
immobilized on a glass coverslip. This specimen was created by placing sev-
eral drops of 1,000-fold diluted stock solution of quantum dots (1 µM) on a
microscope coverslip and drying the solution. Then, the coverslip was placed
on a microscope slide. The space between the coverslip and the slide was
filled with 1% agarose gel to facilitate immobilization of the quantum dots.
From a time series of images of a quantum dot, one can see a character-
istic “blinking” of fluorescence (67), which can be used to identify single
quantum dots.
SI Appendix, Fig. S2 A and B shows images of quantum dots on a glass
slide recorded in 3D, from which we extracted radial (SI Appendix, Fig.
S2C) and axial (SI Appendix, Fig. S2D) distributions of fluorescence intensity
emitted by a selected quantum dot. These distributions agreed well with the
fitted theoretical point-spread function (PSF) of a two-photon microscope,
which is known from the literature (equations 6 and 16 in ref. 68). The the-
oretical PSF was fitted to data based on the following fitting parameters:
location, amplitude, a constant background, and the refractive index of the
immersion medium.
The refractive index, n, defines the width of the fitted PSF, because the
wavelength of the excitation laser, λ, and the collection angle of the objec-
tive, α, are fixed, known values (equation 3 in ref. 69). With the fitted values
of n, we estimated the N.A. of the objective as n · sinα. For the fits shown
in SI Appendix, Fig. S2 C and D, the estimated N.A. values were 1.04± 0.01
and 0.97± 0.07, respectively. These values are consistent with the known
NA = 1.05 of our water-immersion objective. From our collected data, we
concluded that our imaging system performed adequately, to its theoreti-
cal limit.
The fact that the simplest paraxial theory of image formation agrees
well with the data obtained with a relatively high-N.A. objective (N.A. =
1.05) has been explained theoretically and shown experimentally (70, 71).
Consequently, we estimated the resolution of the microscope with theoret-
ical values for the full-width-at-half-maximum (FWHM) of the microscope’s
theoretical PSFs (table 1 and equation 3 in ref. 69). The estimated resolu-
tions, measured from quantum dots on a glass slide, were ∆XY = 0.28 µm
and ∆Z = 1.06 µm.
As in other turbid media, imaging in the brain deteriorates with increas-
ing depth, in both lateral and axial resolutions. We collected fluorescence
intensities at the interface between blood and brain tissues. There, one may
expect a further reduction in resolution, due to a mismatch of refractive
indices. To estimate the two-photon microscope’s resolution there, we used
quantum dots conjugated with WGA lectin, which binds to the endothe-
lial glycocalyx. After a bolus injection of quantum dots (100 µL of a 5-nM
solution), we could identify quantum dots in clusters or in isolation, sparsely
covering the inner surfaces of vessels. SI Appendix, Fig. S3 A and B shows
images of quantum dots inside the brain. We analyzed these images in
the same way that we analyzed the images of quantum dots on a glass
slide. Based on the fits shown in SI Appendix, Fig. S3 C and D, the esti-
mated values of N.A. were 0.61± 0.02 and 0.38± 0.07, respectively. The
effect of the brain, therefore, can be thought of as a reduction in the
“effective” N.A. of the objective, a reduction that differs for the lateral
and axial dimensions. We found that, in the brain, at depths from 50 to
100 µm, ∆XY = 0.49± 0.05µm (mean ± SEM; n = 10 beads from three dif-
ferent mice) and ∆Z = 3.20± 0.18µm (mean ± SEM; n = 10 beads from
three different mice).
Our method for in situ estimation of the resolution of a two-photon
microscope may be useful for other studies that use high-resolution imaging
in the brain. In comparison with the injection of quantum dots or fluores-
cent beads into the brain with a pipette, our method is less invasive and
technically simple (it requires only single i.v. injection), and it can be used
for routine checks of resolution.
Theory. Our model was based on the following assumptions, which are
similar to those of Krogh’s cylinder model (17, 72):
i) The vessel has a cylindrical shape and is oriented perpendicular to the
focal plane.
ii) The distribution of fluorescence intensity in the extravascular compart-
ment has cylinder symmetry.
iii) Diffusion is the only mechanism of transport in the extravascular
compartment.
iv) The studied vessel is the only source of diffusing compound in the
imaging region.
v) The vessel’s diameter does not change during the experiment.
vi) Loss of fluorescence by photobleaching or otherwise can be described
with a first order reaction.
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The flux, J(t), of a fluorescent dye through a unit surface of the BBB is
proportional to its permeability, P:
J(t) = P (Cg(t)− Cev(t)) , [2]
where Cg(t) and Cev(t) are the concentrations of the fluorescent dye in
the glycocalyx and at the inner surface of the extravascular compartment,
respectively (Fig. 2D). We assumed that the measured fluorescence intensity
I(t, r) was proportional to the dye concentration, I(t, r) = K−1 C(r, t), where
K was the proportionality constant.
When the dye was distributed only in the extracellular spaces, not in cells,
the coefficient α could be introduced to estimate the volume fraction of the
extracellular spaces, relative to the total volume of the tissue (43). Then, the
relationship between the fluorescence intensity measured in the extravas-
cular compartment of a vessel, Iev, and the concentration of the dye, Cev,
could be calculated as Cev(t) = K · Iev(t)/α, where 0<α< 1.
We assumed that only a fraction of the glycocalyx volume, αg, was acces-
sible to the fluorescent dye and that an equilibrium existed between the
dye in the plasma and that in the glycocalyx at all times. Accordingly, the
dye’s concentration in the glycocalyx was Cg(t) =αg K Ii(t), where Ii(t) was
the fluorescence intensity in blood plasma. Thus, J(t), from Eq. 2, could be
expressed in terms of the measured fluorescence intensities as follows:
J(t) = P
(
αg K Ii(t)−
1
α
K Iev(t)
)
≈αgP K Ii(t). [3]
The approximate expression was valid for the majority of datasets when
Ii(t) Iev(t).
We used NaF, AF, Dex40, and Dex150 as fluorescent dyes. We assumed
that the dyes moved freely within the vessel and had no interactions
with any blood components (73, 74). We also assumed that the dyes, as
hydrophilic molecules, could not permeate cell membranes but instead
distributed in the extracellular spaces (22, 75).
We showed that the spread of fluorescence of the studied dyes in the
extravascular compartment agreed well with the reaction–diffusion equa-
tion (Eq. 1). The effective diffusion coefficient, D*, was related to the
diffusion constant in free medium (agarose gel), D, and the tortuosity of
the tissue, λ, through λ2 = D/D* (43).
We placed the surface of our model cylinder at the location of the peak of
the SR101 (astrocyte) fluorescence (Fig. 2D). There, we set a time-dependent
boundary condition. SI Appendix, Fig. S5A shows an example of experi-
mentally measured fluorescence intensity at the boundary, Iev(t, R), and its
smoothed version, calculated with a locally weighted scatterplot smoothing
regression.
The second boundary condition was defined by assuming a zero flux far
(R∞) from the cylinder surface. This assumption holds when no molecule
reaches R∞ from the studied vessel or any other vessel during the experi-
ment. In the numerical model, we placed R∞ approximately 30 µm away
from the cylinder surface; thus, R∞ R.
A straightforward way to implement an initial condition for Eq. 1
is to use the measured fluorescence distribution at the initial time,
Iev(t0, r), but this approach has several disadvantages. First, like any exper-
imentally measured intensity profile, the Iev(t0, r) contained noise, which
would influence the fitting, particularly at early times, before the irreg-
ularities of Iev(t0, r) were smoothed by diffusion. Second, the reaction
term kr Iev(r, t) in Eq. 1 depended on the absolute value of fluores-
cence intensity, which could contain dye-independent autofluorescence.
In general, measurements of fluorescence intensity contain both the dye
fluorescence and nonspecific autofluorescence. See SI Appendix for more
theory.
Statistics and Software. Standard statistical tests and open source software
were used for the data analysis. See SI Appendix, Statistics and Software
Libraries.
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